Best Investment Research Software for Financial Advisors and RIAs

The short answer: for a solo RIA or a small firm, Koyfin Advisor Core at $209 a month billed annually is the cheapest advisor tier in the category with a published price, and Koyfin Advisor Pro at $299 is the one most firms end up on because it handles more than one custodian. YCharts and Morningstar are the two names advisors mention most, and neither publishes a price. Nitrogen publishes its Research Center at $149 a month. Below is what each one actually does, read off the vendors' own pages on August 22, 2026, plus the job none of them do.

Advisory firms buy research software for reasons a retail investor never has to think about. You need fund and manager data because clients hold funds. You need output a client will read and a compliance officer will accept. You need it to connect to a custodian, because a research tool that cannot see the actual book is a second place to type the same numbers. That is why the retail tools that dominate every "best stock research" listicle mostly do not appear here, and why the prices are four to ten times higher.

What software do financial advisors use for investment research?

Most practices end up with two or three tools rather than one: a research and data platform, a proposal or risk tool that produces the client-facing document, and portfolio management software that holds the book. This article is about the first one, with the second included where the line blurs, because several vendors now sell both and price them together.

Here is what each publishes, checked directly on the vendors' own pages.

The pattern in that table is the useful part. Two of the three most recommended advisor research tools will not tell you what they cost until you have taken a call. That is not unusual in advisor technology and it is not evidence of anything shady: institutional contracts really do scope on seat count, modules and data rights. It does mean that a genuine like-for-like comparison is impossible from your desk, and it puts the vendors who do publish, Koyfin and Nitrogen, in a stronger position for a small firm than their feature lists alone would suggest.

How much does investment research software cost for advisors?

For a solo advisor with a published price, budget $150 to $300 a month per seat. Koyfin Advisor Core is $209 a month billed annually and Advisor Pro is $299. Nitrogen Research Center is $149 and its Complete Bundle is $495. Where nothing is published, the honest answer is that you will not know before a scoping call, and any specific YCharts or Morningstar figure you read in a blog post is unsourced unless the writer says where it came from.

Two cost details are worth planning around. First, billing term. Koyfin's advisor tiers cost $239 and $349 month to month against $209 and $299 annually, so paying monthly runs 14% to 17% higher, which is $360 to $600 a year on one seat. Nitrogen's published figures are annual-term rates, so a monthly option, if it exists, will not be that number. Second, Koyfin advertises a discount for growing advisory firms under $100 million in AUM and prices it nowhere. If that describes your firm, ask before paying list.

Is Koyfin good for financial advisors?

For a small firm that wants terminal-grade research plus basic client infrastructure without an institutional contract, it is the best published value in the category. Advisor Core at $209 buys model portfolios, client portfolios, branded proposals and reports, one custodian connection, and US and Canadian mutual fund data with a screener, on top of everything in Premium. That is a lot for the money against anything institutional.

Two ceilings decide whether you can stay on Core. It connects to one custodian, and it allows 10 client proposals and reports per month. If any client sits at a second custodian, Core cannot keep the book current in one workflow. Koyfin says most firms choose Pro, and the $90 a month step buys multiple custodians at once, 200 reports a month, custom report pages, US SMAs, short and leveraged models, priority support, and PMS integrations with Black Diamond, Addepar and Orion. The underrated feature on Pro is PDF broker statement upload, which lets you analyze a prospect's current holdings and build a proposal before any assets transfer.

Where Koyfin loses to Morningstar is fund and manager research depth, style analysis, and the ratings language your clients already recognize from their statements. If manager selection is the core of your process, that gap is the whole decision and the unpublished price is worth the call.

Do financial advisors need backtesting software?

Not for every practice, but there is a specific moment when the answer becomes yes: when your investment process contains a rule. Not a philosophy, a rule. "We move to the defensive model when the index closes below its 200-day average." "We rebalance the sleeve when any position drifts more than five points." "We overweight quality when credit spreads widen." Anything you could write as a sentence beginning with "when."

None of the tools in the table above will tell you what that rule did across two decades. Koyfin has no backtesting engine at any tier, and this is the most common misunderstanding about it: Premium's hypothetical performance re-runs a modified version of an allocation you already hold, which is a what-if on a portfolio, not a rule executed day by day across history producing entries, exits, a drawdown curve and a benchmark comparison. Morningstar and YCharts do not run that test either. Portfolio analytics tools test allocations, not signals.

The reason this matters for advisors more than for individuals is the conversation on the other side of it. When a client asks why the model went defensive in March, "because our rule fired, and here is what that rule did through 2008, 2020 and 2022, including the times it was wrong" is a categorically different answer from "because we judged conditions had changed." One of those survives a nervous quarter. The investment research software comparison covers which platforms do and do not include this, and it is close to none of them.

There is a discipline point here too. Bailey, Borwein, Lopez de Prado and Zhu showed in the Notices of the American Mathematical Society in May 2014 that with only five years of daily data, trying more than about 45 independent configurations of a strategy will near enough guarantee an in-sample Sharpe ratio of 1.0 whose expected out-of-sample performance is zero. Testing a rule is valuable. Testing forty variants and presenting the best one to a client is not research, it is selection bias with a chart attached. Test the rule you already believe in, on the longest history you can get, and report the result whichever way it lands.

What is the best research tool for a solo RIA?

Start with Koyfin Advisor Core at $209 a month billed annually and only move up when one of its two ceilings actually binds. It publishes its price, it covers research and client reporting in one subscription, and it does not require a procurement cycle. If manager research is central to how you build portfolios, get a Morningstar quote before deciding, because that is the one capability Koyfin does not match. If your bottleneck is producing the client-facing risk conversation rather than the underlying research, Nitrogen's published tiers are the more direct answer.

One workflow problem that no research vendor solves, and that quietly costs small firms hours a week: the research a practice has already done. The IPS documents, the meeting notes, the due diligence memo on the fund you evaluated eighteen months ago, the email where you explained your rebalancing policy to a client. That material is usually spread across a drive, a CRM and three inboxes, and the usual fix is to redo the work. A tool that can search across every document the firm has already produced is a cheaper answer than a bigger research subscription, and it is a different purchase from the ones in the table above.

The short version

Koyfin publishes advisor pricing at $209 and $299 a month billed annually and is the strongest published value for a small firm. Nitrogen publishes too, from $149 for Research Center up to $495 for the Complete Bundle on annual terms. YCharts, Morningstar Advisor Workstation, Morningstar Direct and AlphaSense publish nothing, so budget a scoping call. Price the published options first so you walk into that call knowing exactly which capability is missing, which is the single most useful thing you can bring to it.

And whichever you choose, note what you are not buying. Every tool here answers what an investment looks like now or looked like then. None answers whether the rule behind your process has ever worked. Tools built for backtesting for financial advisors and RIAs handle that job, the wider budget question is covered in how much stock analysis software costs, and the full tier-by-tier breakdown of the cheapest published option is on Koyfin pricing.

Educational analysis only, not investment advice. Past performance does not guarantee future results. Prices were read at each vendor on the dates noted and change without notice.